Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Status:
Terminated
Trial end date:
2020-11-26
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to assess the efficacy and safety of two doses of
vilaprisan compared to placebo in women with symptomatic endometriosis.
The secondary objective of this study was to evaluate the safety and tolerability of two
different doses of vilaprisan in women with symptomatic endometriosis.
With the implementation of protocol amendment 6, no new subjects were enrolled. The
objectives above cannot be reached as only limited data is available from subjects recruited
before the temporary pause.